Counter-Terrorism Focus, Regulatory Reform Plans Will Impact CDRH
This article was originally published in The Silver Sheet
Executive Summary
NEW FDA COUNTER-TERRORISM INITIATIVES are slated to receive the bulk of any funding increase in FY 2003, leaving little monies for already cash-strapped day-to-day operations. Despite an influx of new hires, the Bush Administration’s goal of a six-fold increase in import product examinations could constrain field efforts to maintain current manufacturer inspection levels. While FDA adjusts its mission focus, consolidation plans within both HHS and FDA are expected to create more streamlined and unified operations. In the midst of these changes, Congress is set to take up a package of medical device reform measures and HHS is reviewing recommendations to ease FDA administrative burdens
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.